Eric J. Duncavage

5.8k total citations
27 papers, 711 citations indexed

About

Eric J. Duncavage is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric J. Duncavage has authored 27 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Eric J. Duncavage's work include Acute Myeloid Leukemia Research (19 papers), Cancer Genomics and Diagnostics (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Eric J. Duncavage is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Cancer Genomics and Diagnostics (12 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Eric J. Duncavage collaborates with scholars based in United States, Sweden and France. Eric J. Duncavage's co-authors include Haley Abel, John D. Pfeifer, Philippe Szankasi, Todd W. Kelley, Bevan Tandon, David Wang, David H. Spencer, Vincent Magrini, Ryan Demeter and Cara Lunn Shirai and has published in prestigious journals such as Blood, Cancer Cell and The American Journal of Surgical Pathology.

In The Last Decade

Eric J. Duncavage

25 papers receiving 702 citations

Peers

Countries citing papers authored by Eric J. Duncavage

Since Specialization

Citations

This map shows the geographic impact of Eric J. Duncavage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Duncavage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Duncavage more than expected).

Fields of papers citing papers by Eric J. Duncavage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric J. Duncavage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Duncavage. The network helps show where Eric J. Duncavage may publish in the future.

Co-authorship network of co-authors of Eric J. Duncavage

This figure shows the co-authorship network connecting the top 25 collaborators of Eric J. Duncavage. A scholar is included among the top collaborators of Eric J. Duncavage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric J. Duncavage. Eric J. Duncavage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma 2025 ·BMC Cancer ·Jeffrey Hiken, (unknown), Kevin C. Flanagan, (unknown), (unknown), D. Messina, Jarret Glasscock, Eric J. Duncavage	1
2	1242 Identification of UBTF-Tandem Duplications in Adult MDS/AML Patients via Whole Genome Sequencing 2025 ·Laboratory Investigation ·(unknown), Eric J. Duncavage, Andrew Hughes	0
3	A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets 2025 ·International Journal of Gynecological Cancer ·Mark C. Valentine, Amanda Wong, Ling Chen, Feiyu Du, Andrew Hughes, David H. Spencer, Eric J. Duncavage, Lulu Sun	0
4	Genomic landscape of TP53-mutated myeloid malignancies 2023 ·Zenodo (CERN European Organization for Nuclear Research) ·Haley Abel, Karolyn A. Oetjen, Christopher A. Miller, Sai Mukund Ramakrishnan, Ryan B. Day, Nichole Helton, Catrina C. Fronick, Robert S. Fulton, Sharon E. Heath, (unknown), Sridhar Nonavinkere Srivatsan, Eric J. Duncavage, Molly C. Schroeder, Jacqueline E. Payton, David H. Spencer, Matthew J. Walter, (unknown), John F. DiPersio, Timothy J. Ley, Daniel C. Link	1
5	Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report 2023 ·Cancer Genetics ·Bahareh A. Mojarad, Zachary Crees, Molly C. Schroeder, Zhifu Xiang, Justin Vader, (unknown), Meagan A. Jacoby, John L. Frater, Eric J. Duncavage, David H. Spencer, Kory J. Lavine, Julie Neidich, Ina Amarillo	2
6	Clinical whole‐genome sequencing in cancer diagnosis 2022 ·Human Mutation ·Ying‐Chen Claire Hou, Julie Neidich, Eric J. Duncavage, David H. Spencer, Molly C. Schroeder	13
7	Distinctive Flow Cytometric and Mutational Profile of Acute Myeloid Leukemia With t(8;16)(p11;p13) Translocation 2021 ·American Journal of Clinical Pathology ·(unknown), Juehua Gao, (unknown), Madina Sukhanova, Eric J. Duncavage, Xinyan Lu, Kristy Wolniak, Friederike Kreisel, Nabeel R. Yaseen	3
8	TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98–HOXD13 mouse model of MDS 2020 ·Experimental Hematology ·Darlene Monlish, Zev J. Greenberg, Sima Bhatt, (unknown), (unknown), Dong Qian, (unknown), Eric J. Duncavage, Jeffrey A. Magee, Laura G. Schuettpelz	12
9	Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia 2020 ·Frontiers in Cell and Developmental Biology ·(unknown), Cara Lunn Shirai, Eric J. Duncavage	31
10	JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells 2018 ·Cancer Cell ·Hamza Celik, (unknown), Ashley C. Kramer, Elizabeth L. Ostrander, Cates Mallaney, Daniel A.C. Fisher, Jingyu Xiang, William C. Wilson, Andrew Martens, (unknown), (unknown), Eric Tycksen, Darja Karpova, Eric J. Duncavage, Young-Sook Lee, Stephen T. Oh, Grant A. Challen	39
11	Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant 2018 ·JCI Insight ·Meagan A. Jacoby, Eric J. Duncavage, Gue Su Chang, Christopher A. Miller, Jin Shao, Kevin Elliott, Joshua D. Robinson, Robert S. Fulton, Catrina C. Fronick, Michelle D. O’Laughlin, Sharon E. Heath, Iskra Pusic, John S. Welch, Daniel C. Link, John F. DiPersio, Peter Westervelt, Timothy J. Ley, Timothy A. Graubert, Matthew J. Walter	36
12	Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs12) from artifact in myeloid malignancies using NGS 2018 ·Leukemia* ·Michael O. Alberti, Sridhar Nonavinkere Srivatsan, Jin Shao, Samantha N. McNulty, Gue Su Chang, Christopher A. Miller, Jennifer Dunlap, Fei Yang, Richard D. Press, Qingsong Gao, Li Ding, Jonathan W. Heusel, Eric J. Duncavage, Matthew J. Walter	19
13	Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant 2017 ·Blood ·Meagan A. Jacoby, Eric J. Duncavage, Gue Su Chang, Christopher A. Miller, Jin Shao, (unknown), Joshua D. Robinson, Robert S. Fulton, Catrina C. Fronick, Michelle D. O’Laughlin, Daniel C. Link, John F. DiPersio, Peter Westervelt, Timothy J. Ley, Timothy A. Graubert, Matthew J. Walter	1
14	A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia 2016 ·Molecular Case Studies ·Charles Lu, Peter A. Riedell, Christopher A. Miller, Ian S. Hagemann, Peter Westervelt, Bradley A. Ozenberger, Michelle D. O’Laughlin, Vincent Magrini, Ryan Demeter, Eric J. Duncavage, Malachi Griffith, Obi L. Griffith, Lukas D. Wartman	15
15	Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches 2013 ·Cancer Genetics ·Haley Abel, Eric J. Duncavage	93
16	Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia 2012 ·Modern Pathology ·Eric J. Duncavage, Haley Abel, Philippe Szankasi, Todd W. Kelley, John D. Pfeifer	65
17	Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data 2012 ·Journal of Molecular Diagnostics ·David H. Spencer, Haley Abel, Christina M. Lockwood, Jacqueline E. Payton, Philippe Szankasi, Todd W. Kelley, Shashikant Kulkarni, John D. Pfeifer, Eric J. Duncavage	92
18	Feasibility and Dosimetry Studies for ¹⁸F-NOS as a Potential PET Radiopharmaceutical for Inducible Nitric Oxide Synthase in Humans 2012 ·Journal of Nuclear Medicine ·Pilar Herrero, Richard Laforest, Kooresh I. Shoghi, Dong Zhou, Gregory A. Ewald, John D. Pfeifer, Eric J. Duncavage, (unknown), Robert H. Mach, Robert J. Gropler	22
19	Hybrid Capture and Next-Generation Sequencing Identify Viral Integration Sites from Formalin-Fixed, Paraffin-Embedded Tissue 2011 ·Journal of Molecular Diagnostics ·Eric J. Duncavage, Vincent Magrini, Nils Becker, Jon R. Armstrong, Ryan Demeter, Todd Wylie, Haley Abel, John D. Pfeifer	83
20	Merkel Cell Polyomavirus 2009 ·The American Journal of Surgical Pathology ·Eric J. Duncavage, (unknown), David Wang, John D. Pfeifer	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact